相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Ho-June Lee et al.
CANCER CELL (2014)
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
Johanna C. Bendell et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Novel inhibitors of signal transducer and activator of transcription 3 (STAT3) show potent activity in cell cultures and tumor xenografts
Davide Genini et al.
CANCER RESEARCH (2014)
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Hanna L. M. Koskela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mitochondrial Localized STAT3 Is Involved in NGF Induced Neurite Outgrowth
Lihan Zhou et al.
PLOS ONE (2011)
Targeting STAT3 in cancer: how successful are we?
Pedbin Yue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor
JV Alvarez et al.
CANCER RESEARCH (2006)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
分享论文
